Evidence map›Paper›PMID 23266520›Full record

ReviewAutoimmunity reviews2013

Infectome: a platform to trace infectious triggers of autoimmunity.

Dimitrios P Bogdanos, Daniel S Smyk, Pietro Invernizzi, Eirini I Rigopoulou, Miri Blank, Shideh Pouria, Yehuda Shoenfeld

Open access · greenAbstract readReview
In one paragraph

Review in Autoimmunity reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Fly Me to the Immune: Immunonutrition in Rheumatic Diseases.Mediterranean journal of rheumatology · 2023
    Article
  10. New insights into pathogenesis of IgA nephropathy.International urology and nephrology · 2022
    Review
  11. The Role of Exposomes in the Pathophysiology of Autoimmune Diseases II: Pathogens.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Triggers of Inflammatory Heart Disease.Frontiers in cell and developmental biology · 2020
    Review
  19. Article
  20. Mediterranean journal of rheumatology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Dimitrios P BogdanosInstitute of Liver Studies, King's College London School of Medicine at King's College Hospital, Denmark Hill Campus, London, UK. dimitrios.bogdanos@kcl.ac.uk
Daniel S Smyk
Pietro Invernizzi
Eirini I Rigopoulou
Miri Blank
Shideh Pouria
Yehuda Shoenfeld
Sheba Medical Center · ILUniversity of Thessaly · GRHumanitas University · ITKing's College Hospital · GBKing's College School · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The "exposome" is a term recently used to describe all environmental factors, both exogenous and endogenous, which we are exposed to in a lifetime. It represents an important tool in the study of autoimmunity, complementing classical immunological research tools and cutting-edge genome wide association studies (GWAS). Recently, environmental wide association studies (EWAS) investigated the effect of environment in the development of diseases. Environmental triggers are largely subdivided into infectious and non-infectious agents. In this review, we introduce the concept of the "infectome", which is the part of the exposome referring to the collection of an individual's exposures to infectious agents. The infectome directly relates to geoepidemiological, serological and molecular evidence of the co-occurrence of several infectious agents associated with autoimmune diseases that may provide hints for the triggering factors responsible for the pathogenesis of autoimmunity. We discuss the implications that the investigation of the infectome may have for the understanding of microbial/host interactions in autoimmune diseases with long, pre-clinical phases. It may also contribute to the concept of the human body as a superorganism where the microbiome is part of the whole organism, as can be seen with mitochondria which existed as microbes prior to becoming organelles in eukaryotic cells of multicellular organisms over time. A similar argument can now be made in regard to normal intestinal flora, living in symbiosis within the host. We also provide practical examples as to how we can characterise and measure the totality of a disease-specific infectome, based on the experimental approaches employed from the "immunome" and "microbiome" projects.

Indexed as

AutoimmunityAnimalsAutoantibodiesAutoimmune DiseasesCommunicable DiseasesHumansProteomeAutoantibodiesProteome

Identifiers

PMID23266520
PMCPMC7105216
OpenAlexW2047485710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.